Literature DB >> 21281437

Assessment of adrenal function in cirrhotic patients using concentration of serum-free and salivary cortisol.

Thierry Thevenot1, Sophie Borot, Agnès Remy-Martin, Remy Sapin, Jean-Paul Cervoni, Carine Richou, Claire Vanlemmens, Denis Cleau, Emilie Muel, Anne Minello, Simona Tirziu, Alfred Penfornis, Vincent Di Martino, Elisabeth Monnet.   

Abstract

OBJECTIVE: Because over 90% of serum cortisol is bound to albumin and corticosteroid-binding globulin (CBG), changes in these proteins can affect measures of serum total cortisol levels in cirrhotics without altering serum-free and salivary cortisol concentrations.
METHODS: We assessed basal (T₀) and post-synacthen (T₆₀) serum total cortisol, serum-free and salivary cortisol in 125 consecutive cirrhotics (95 non-septic and 30 septic patients with a Child>8).
RESULTS: Serum total cortisol levels significantly decreased from the Child A-C non-septic group, as did albumin and CBG levels, with a non-significant rise in serum-free cortisol concentrations. Non-septic patients with low albumin (≤25 g/L) or CBG levels (≤35 mg/L) had lower T₀ serum total cortisol levels than patients with near-normal albumin (303.4 vs. 382.6 nmol/L; P=0.0035) or with normal CBG levels (289.9 vs. 441.4 nmol/L; P<0.0001), respectively, despite similar serum-free cortisol or salivary cortisol concentrations. Subnormal T₆₀ serum total cortisol concentrations (<510.4 nmol/L) were measured in 7.2% of all patients (Child C: 14.5% vs. Child A and B: 0%; P=0.0013) but no patients exhibited symptoms suggesting adrenal insufficiency. Patients with or without subnormal T₆₀ total cortisol had similar T₀ salivary cortisol and serum-free cortisol concentrations. A trend was observed towards high serum-free cortisol concentrations and mortality in multivariate analysis.
CONCLUSIONS: Serum total cortisol levels overestimated the prevalence of adrenal dysfunction in cirrhotics with end-stage liver disease. Since serum-free cortisol cannot be measured routinely, salivary cortisol testing could represent a useful approach but needs to be standardized.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281437     DOI: 10.1111/j.1478-3231.2010.02431.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  19 in total

Review 1.  Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.

Authors:  Gaetano Bertino; Graziella Privitera; Francesco Purrello; Shirin Demma; Emanuele Crisafulli; Luisa Spadaro; Nikolaos Koukias; Emmanuel A Tsochatzis
Journal:  Intern Emerg Med       Date:  2016-06-07       Impact factor: 3.397

2.  Enhanced cosyntropin stimulation test performance enabled by electronic medical record.

Authors:  Anat Ben-Shlomo; Joseph Guzman; James Mirocha
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

Review 3.  Regulation of cortisol bioavailability--effects on hormone measurement and action.

Authors:  Ilias Perogamvros; David W Ray; Peter J Trainer
Journal:  Nat Rev Endocrinol       Date:  2012-08-14       Impact factor: 43.330

4.  Plasma Free Cortisol in States of Normal and Altered Binding Globulins: Implications for Adrenal Insufficiency Diagnosis.

Authors:  Laura E Dichtel; Melanie Schorr; Claudia Loures de Assis; Elizabeth M Rao; Jessica K Sims; Kathleen E Corey; Puja Kohli; Patrick M Sluss; Michael J McPhaul; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 5.  New prognostic markers in liver cirrhosis.

Authors:  Vincent Di Martino; Delphine Weil; Jean-Paul Cervoni; Thierry Thevenot
Journal:  World J Hepatol       Date:  2015-05-28

Review 6.  Update on adrenal insufficiency in patients with liver cirrhosis.

Authors:  Anca Trifan; Stefan Chiriac; Carol Stanciu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 7.  Adrenal insufficiency in patients with decompensated cirrhosis.

Authors:  Apostolos Ka Karagiannis; Theodora Nakouti; Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2015-05-18

8.  Cosyntropin-Stimulated Serum Free Cortisol in Healthy, Adrenally Insufficient, and Mildly Cirrhotic Populations.

Authors:  Mitra Rauschecker; Smita Baid Abraham; Brent S Abel; Robert Wesley; Elizabeth Saverino; Apurva Trivedi; Theo Heller; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2015-12-08       Impact factor: 5.958

9.  ASSESSMENT OF ADRENOCORTICAL DYSFUNCTION IN PATIENTS WITH STABLE LIVER CIRRHOSIS.

Authors:  Ş Chiriac; C Stanciu; R Negru; A Trifan
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

10.  Decreased maximal cortisol secretion rate in patients with cirrhosis: Relation to disease severity.

Authors:  Christina M Lovato; Thierry Thévenot; Sophie Borot; Vincent Di Martino; Clifford R Qualls; Frank K Urban; Richard I Dorin
Journal:  JHEP Rep       Date:  2021-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.